Patents by Inventor Vijay Sidram Benade

Vijay Sidram Benade has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pyrrolo[1,2-b]-2-pyridazinone compounds as 5-HT4 receptor agonists
    Patent number: 12275746
    Abstract: The present invention relates to pyrrolo[1,2-b]-2-pyridazinone compounds of formula (I), or their isotopic forms, stereoisomers, or pharmaceutically acceptable salts thereof as 5-HT4 receptor agonists. The present invention also describes methods of making such compounds, pharmaceutical compositions comprising such compounds, and their use in the treatment of gastrointestinal disease or disorder.
    Type: Grant
    Filed: January 10, 2023
    Date of Patent: April 15, 2025
    Assignee: SUVEN LIFE SCIENCES LIMITED
    Inventors: Ramakrishna Nirogi, Anil Karbhari Shinde, Abdul Rasheed Mohammed, Vinod Kumar Goyal, Santosh Kumar Pandey, Vijay Sidram Benade, Venkatesh Goura, Venkateswarlu Jasti
  • Method of treatment with histamine-3 receptor inverse agonist
    Patent number: 11622967
    Abstract: The present invention provides new methods of treatment for narcolepsy, excessive daytime sleepiness, obstructive sleep apnea, circadian rhythm sleep disorders, sleep and vigilance disorders associated with Parkinson's disease, multiple sclerosis, dementia or attention deficit hyperactivity disorder by administering a therapeutically effect amount of histamine-3 receptor (H3R) inverse agonist, N-[4-(1-Cyclobutylpiperidin-4-yloxy)phenyl]-2-(morpholin-4-yl)acetamide or a pharmaceutically acceptable salt thereof. The present invention further provides use of the said compounds in the manufacture of medicament intended for the treatment of the disorders described herein.
    Type: Grant
    Filed: August 1, 2018
    Date of Patent: April 11, 2023
    Assignee: SUVEN LIFE SCIENCES LIMITED
    Inventors: Ramakrishna Nirogi, Anil Karbhari Shinde, Vijay Sidram Benade, Saivishal Daripelli, Pradeep Jayarajan, Jyothsna Ravula, Venkateswarlu Jasti
  • Fluoroindole derivatives as muscarinic M1 receptor positive allosteric modulators
    Patent number: 10294217
    Abstract: The present invention relates to compound of formula (I), or stereoisomers and pharmaceutically acceptable salts as muscarinic M1 receptor positive allosteric modulators. This invention also relates to methods of making such compounds and pharmaceutical compositions comprising such compounds. The compounds of this invention are useful in the treatment of various disorders that are related to muscarinic M1 receptor.
    Type: Grant
    Filed: July 19, 2016
    Date of Patent: May 21, 2019
    Assignee: Suven Life Sciences Limited
    Inventors: Ramakrishna Nirogi, Anil Karbhari Shinde, Abdul Rasheed Mohammed, Ramkumar Subramanian, Vijay Sidram Benade, Gopinadh Bhyrapuneni, Venkateswarlu Jasti
  • Fluoroindole Derivatives as Muscarinic M1 Receptor Positive Allosteric Modulators
    Publication number: 20180244655
    Abstract: The present invention relates to compound of formula (I), or stereoisomers and pharmaceutically acceptable salts as muscarinic M1 receptor positive allosteric modulators. This invention also relates to methods of making such compounds and pharmaceutical compositions comprising such compounds. The compounds of this invention are useful in the treatment of various disorders that are related to muscarinic M1 receptor.
    Type: Application
    Filed: July 19, 2016
    Publication date: August 30, 2018
    Applicant: Suven Life Sciences Limited
    Inventors: Ramakrishna Nirogi, Anil Karbhari Shinde, Abdul Rasheed Mohammed, Ramkumar Subramanian, Vijay Sidram Benade, Gopinadh Bhyrapuneni, Venkateswarlu Jasti